#Selex

[xedientrungnam]

[cgvijesti]

Opljačkana pumpa, razbojnici pištoljem otuđili novac

U sarajevskom naselju Hrasno juče je u 2:13 sati u ulici Milana Preloga došlo do oružane pljačke benzinske pumpe “Selex”, prenosi Klix ba. Policijska uprava Novi Grad Sarajevo juče je dobila obavještenje da je od strane dvije NN osobe izvršeno krivično djelo razbojništva nad uposlenicima ove pumpe. Tom prilikom NN osobe su uz prijetnju pištoljem otuđile određenu sumu novca, a zatim se udaljili…

[tintucxedien]

Selex Camel – Xe máy điện giao hàng của Selex Motors giá 21.890.000 đồng

Mẫu xe máy điện Selex Camel (Con lạc đà) chuyên dùng để chở hàng phù hợp với các công ty chuyển phát giao hàng chặng cuối cho thương mại điện tử có khả năng đổi pin ở trạm đổi pin tự động, được nhà sản xuất cho thuê pin tính theo số km.

[splicejunction]

hello sorry if this is weird but i sort of remember you saying you work with selex (?) i’m part of a team of undergrads rn working on building aptasensors only we don’t have the money for selex lol 💀 do you know of any cheaper ways (preferably computational) we can use for selection and optimisation

not weird at all science asks are my favorite type of ask to receive for real :D

I'm assuming you're talking about RNA aptamers, I have never used any computational methods for designing RNA aptamers/aptasensors myself. I did a quick search and I found this paper:

In silico selection of RNA aptamers, Nucleic Acids Research, https://doi.org/10.1093/nar/gkp408

Our approach consists of three steps: (i) selection of RNA sequences based on their secondary structure, (ii) generating a library of three-dimensional (3D) structures of RNA molecules and (iii) high-throughput virtual screening of this library to select aptamers with binding affinity to a desired small molecule.

I can't speak to how well this works because I haven't used it, but it looks like it worked for them. there's also this review apparently:

In-Silico Selection of Aptamer: A Review on the Revolutionary Approach to Understand the Aptamer Design and Interaction Through Computational Chemistry, https://doi.org/10.1016/j.matpr.2019.11.185 (paywalled but pdf here)

designing aptamers in silico from random sequence relies on RNA 3D structure prediction which is.... getting better, but we don't really have an equivalent of Alphafold yet for RNA structure. designing aptamers computationally would require simulating RNA structure and complexation with ligands and I just don't know if our current 3D structure prediction methods are good enough for that, but you could give it a try, & if you do you let me know how it goes!!

I would love to hear more about your project like what ligand you're trying to bind & what aspects of SELEX are cost-prohibitive (do you have any budget for wet-lab work/materials?)

[limoteesese]

MLB Colorado Rockies Grinch Christmas Sweater Design

MLB Colorado Rockies Grinch Christmas Sweater Design

Grifo radar is multi-mode pulse Doppler all weather fire control radar. PAC has the MLB Colorado Rockies Grinch Christmas Sweater Design of not only producing the airborne fire control radars but also has vast experience in maintaining three variants of Grifo radars. PAC has produced a number of Grifo radar systems for PAF Fleet in collaboration with M/S Selex Electronic Systems Italy. Grifo family of radars is digital fire control system designed to improve air to air and air to ground performance. Radars are capable of detecting and tracking the targets at all altitudes and all aspects. Radars have powerful and accurate Built-In Test (BIT) system followed by auto calibration for the ease of smooth operation and better maintenance.

[latestmarketresearchnews]

Aptamers Market - Structure, Size, Trends, Analysis and Outlook 2030

The global aptamers market was valued at USD 1.94 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 24.54% from 2023 to 2030. This rapid growth is being driven by significant advancements in the development, purification, and drug delivery systems for targeting and eliminating harmful cells, which have garnered the attention of researchers. Aptamers possess several competitive advantages over traditional antibodies, including smaller molecular size, lower immunogenicity (reduced immune response), reduced manufacturing costs, and fewer side effects. These benefits are encouraging research and development (R&D) efforts in the creation of new aptamers, fueling market expansion.

Despite considerable research, no highly effective treatments for COVID-19 have been identified, partly due to the virus's extensive genetic mutations. However, biotechnological approaches, including the use of aptamers, hold promise in combating COVID-19 infections. Nucleic acid-based aptamers and peptide aptamers are believed to offer potential therapeutic solutions for the virus, and various government initiatives are supporting the development of novel treatments for COVID-19. For example, in September 2020, the Department of Community & Economic Development awarded USD 320,000 to Aptagen LLC to fund research and development of a novel COVID-19 treatment. This investment reflects the growing recognition of aptamers' potential in addressing unmet medical needs.

Gather more insights about the market drivers, restrains and growth of the Aptamers Market

Aptamers are also proving valuable in diagnostics. Using SELEX (Systematic Evolution of Ligands by Exponential Enrichment) technology, aptamer-based diagnostic kits and assays can develop high-affinity neutralizers and bioprobes for detecting SARS-CoV-2 and other COVID-19 biomarkers. These innovations are expected to further drive market growth. For example, in December 2021, Achiko AG received approval from the Indonesian Ministry of Health for its COVID-19 diagnostic kit, Aptamex. Aptamex is a second-generation, cost-effective diagnostic tool based on DNA aptamer technology, representing an emerging solution in healthcare diagnostics.

Type Segmentation Insights:

The aptamers market is segmented into nucleic acid aptamers and peptide aptamers. In 2022, the nucleic acid aptamers segment dominated the market, holding a 78.19% share, and is expected to exhibit the highest growth during the forecast period. Many companies are actively exploring the therapeutic mechanisms of nucleic acid aptamers for treating various disorders, such as age-related macular degeneration (AMD). For instance, in June 2021, the U.S. Food and Drug Administration (FDA) granted IVERIC BIO (formerly Ophthotech Corporation) a written agreement under the Special Protocol Assessment (SPA) for the design of its phase 3 clinical trial, GATHER2. The trial aims to assess the efficacy of Zimura, a nucleic acid aptamer-based drug, for patients with geographic atrophy (GA) secondary to AMD. This FDA approval is expected to significantly bolster the growth of the nucleic acid aptamer segment.

The peptide aptamer segment is anticipated to experience substantial growth, with a projected CAGR of 22.77% from 2023 to 2030, driven by its broad applications in diagnostics and therapeutics. For instance, in August 2021, scientists from the Engineering Center for Microtechnology and Diagnostics developed an innovative biosensor for multiparametric express testing in the preclinical diagnostics of cardiovascular diseases. This testing uses next-generation biochips, which are based on a peptide aptamer marker system and molecular recognition technology. The researchers designed peptide aptamers using data from the Data Bank and Protein 3D software. The introduction of such advanced products in the market is likely to increase the utilization of peptide aptamers, contributing to the segment's growth.

In summary, the aptamers market is poised for rapid expansion due to the advantages of aptamers in therapeutic and diagnostic applications, advancements in technology, and ongoing R&D efforts. The market's growth is further supported by government initiatives, regulatory approvals, and the increasing use of aptamer-based solutions in areas such as COVID-19 treatment, diagnostics, and the management of other medical conditions.

Order a free sample PDF of the Aptamers Market Intelligence Study, published by Grand View Research.

[teejeepclothes]

American Aquarium Oct 3 2024 The Hi Fi Indianapolis in Indianapolis IN Tour Poster Shirt

American Aquarium Oct 3 2024 The Hi Fi Indianapolis in Indianapolis IN Tour Poster Shirt Grifo radar is multi-mode pulse Doppler all weather fire control radar. PAC has the American Aquarium Oct 3 2024 The Hi Fi Indianapolis in Indianapolis IN Tour Poster Shirt of not only producing the airborne fire control radars but also has vast experience in maintaining three variants of Grifo radars. PAC has produced a number of Grifo radar systems for PAF Fleet in collaboration with M/S Selex Electronic Systems Italy. Grifo family of radars is digital fire control system designed to improve air to air and air to ground performance. Radars are capable of detecting and tracking the targets at all altitudes and all aspects. Radars have powerful and accurate Built-In Test (BIT) system followed by auto calibration for the ease of smooth operation and better maintenance.

[limoteesjr]

Shohei Ohtani Sets A New Dodger Franchise Record For Home Runs In A Single Season With 50 Vintage T Shirt

Shohei Ohtani Sets A New Dodger Franchise Record For Home Runs In A Single Season With 50 Vintage T Shirt Grifo radar is multi-mode pulse Doppler all weather fire control radar. PAC has the Shohei Ohtani Sets A New Dodger Franchise Record For Home Runs In A Single Season With 50 Vintage T Shirt of not only producing the airborne fire control radars but also has vast experience in maintaining three variants of Grifo radars. PAC has produced a number of Grifo radar systems for PAF Fleet in collaboration with M/S Selex Electronic Systems Italy. Grifo family of radars is digital fire control system designed to improve air to air and air to ground performance. Radars are capable of detecting and tracking the targets at all altitudes and all aspects. Radars have powerful and accurate Built-In Test (BIT) system followed by auto calibration for the ease of smooth operation and better maintenance.

[strawberryclothing]

Nebraska Huskers On Saturdays X Kansas City Chiefs On Sundays Shirt

Nebraska Huskers On Saturdays X Kansas City Chiefs On Sundays Shirt Grifo radar is multi-mode pulse Doppler all weather fire control radar. PAC has the Nebraska Huskers On Saturdays X Kansas City Chiefs On Sundays Shirt of not only producing the airborne fire control radars but also has vast experience in maintaining three variants of Grifo radars. PAC has produced a number of Grifo radar systems for PAF Fleet in collaboration with M/S Selex Electronic Systems Italy. Grifo family of radars is digital fire control system designed to improve air to air and air to ground performance. Radars are capable of detecting and tracking the targets at all altitudes and all aspects. Radars have powerful and accurate Built-In Test (BIT) system followed by auto calibration for the ease of smooth operation and better maintenance.

[teejeep-shirt]

Duck Bill shirt

Duck Bill shirt Grifo radar is multi-mode pulse Doppler all weather fire control radar. PAC has the Duck Bill shirt of not only producing the airborne fire control radars but also has vast experience in maintaining three variants of Grifo radars. PAC has produced a number of Grifo radar systems for PAF Fleet in collaboration with M/S Selex Electronic Systems Italy. Grifo family of radars is digital fire control system designed to improve air to air and air to ground performance. Radars are capable of detecting and tracking the targets at all altitudes and all aspects. Radars have powerful and accurate Built-In Test (BIT) system followed by auto calibration for the ease of smooth operation and better maintenance.

[xedientrungnam]

Tiệm kiệm cả triệu đồng mỗi tháng với xe máy điện Selex

[colinwilson11]

Global DNA Encoded Library Market Will Grow At Highest Pace Owing To Rising Demand For Targeted Drug Discovery

DNA encoded library is an innovative approach that employs DNA sequences to encode large chemical libraries for drug discovery. DNA encoded libraries provide advantages like screening of millions of compounds in parallel and facilitating drug discovery research. The technique involves encoding large collections of small molecules, peptides or oligonucleotides with short DNA tags and then screening them for potential hits. This enables high-throughput screens focusing on specific targets for applications in drug discovery, chemical biology and systematic evolution of ligands by exponential enrichment (SELEX).

The Global DNA Encoded Library Market is estimated to be valued at US$ 0.8 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2024-2031.

Key Takeaways

Key players operating in the Global DNA Encoded Library are BOC Sciences, DyNAbind, Edelris, GenScript, and HitGen. These players are adopting strategies like collaborations, investments in R&D and new product launches to strengthen their market position. The growing demand for effective therapeutics against various diseases is also boosting the demand for DNA encoded library-based drug discovery worldwide. Additionally, technological advancements like next generation sequencing and mass spectrometry is further enhancing the screening capabilities and fueling the growth of this market.

Market Trends

Some of the key trends driving the growth of the Global DNA Encoded Library market include rising adoption of DNA-encoded library techniques by pharmaceutical companies and growth of clinical trials. The traditional drug discovery methods are being replaced with DNA-encoded techniques owing to their advantages. They enable screening libraries of billions of compounds efficiently in a high-throughput manner. Another trend is the increasing partnerships between technology providers and end-users to accelerate the drug discovery process using DNA-encoded library platforms.

Market Opportunities

The untapped potential of emerging economies and growing research in genomic applications presents huge opportunities for players in this market. Rapid advances in DNA synthesis and sequencing technologies are further expanding the applications of DNA-encoded libraries. Adoption of artificial intelligence and machine learning can also enhance the screening and data analysis capabilities. Development of customized DNA-encoded libraries focused on specific disease pathways will witness high demand in coming years.

Impact Of Covid-19 On Global DNA Encoded Library Market Growth:

The outbreak of Covid-19 pandemic severely impacted the growth of global DNA encoded library market in the initial months of 2020. Various social restrictions imposed by governments like lockdowns and social distancing norms disrupted the supply chain and halted research activities at labs and research institutions globally. This led to delays in drug discovery programs utilizing DNA encoded libraries. Many biopharma companies also shifted resources to focus on Covid-19 vaccine and treatment research in the short term.

However, as research communities and industries adapted to the new normal, activity levels recovered gradually in 2021. The pandemic also highlighted the importance of therapeutics for infectious diseases, boosting investment in areas like antibiotic discovery utilizing DNA encoded libraries. Many players in the market also expedited development of Covid-19 antiviral and treatment libraries. Going forward, market players are focusing on digitalization of operations and remote collaborations to make discovery processes more resilient to future disruptions. Governments are also providing increased funding for genomics and biotech to accelerate development of new drugs.

Concentration Of Global DNA Encoded Library Market In Terms Of Value:

North America region currently accounts for the largest share of global DNA encoded library market in terms of value, estimated at over 40% in 2024. This is due to presence of major pharmaceutical players and contract research organizations (CROs) actively utilizing these libraries for drug discovery programs in the US and Canada. Countries like the US also provide favorable funding environment for genomic and biotech research. Europe is the second largest regional market led by presence of large pharma companies and academic research institutes in countries like UK, Germany and France. The market is also witnessing fastest growth in Asia Pacific region led by China and India. This is attributed to increasing government investments in healthcare sector, emerging biotech industry and growing expertise in DNA sequencing and library construction technologies.

Fastest Growing Region In The Global DNA Encoded Library Market:

Asia Pacific region is poised to emerge as the fastest growing regional market for DNA encoded libraries during the forecast period from 2024 to 2031. This growth can be attributed to increasing government emphasis and funding for research in genomics, biotech and synthetic biology in emerging economies like China and India. Favorable business environment and presence of skilled labor are also attracting many global library developers and pharmaceutical companies to set up research and manufacturing facilities in the region. In addition, the region provides significant cost advantages compared to developed markets for drug discovery processes. With improving standards and widespread adoption of DNA encoded library technologies, Asia Pacific will continue dominating the growth of worldwide market in the coming years.

Get more insights on this topic:   https://www.pressreleasebulletin.com/global-dna-encoded-library-market-set-for-high-growth-due-to-advancements-in-dna-screening-technologies/

Author Bio:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163 )

What Are The Key Data Covered In This Global DNA Encoded Library Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the Global DNA Encoded Library Market's growth between 2024 and 2031.

:- Accurate calculation of the size of the Global DNA Encoded Library Market and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- Global DNA Encoded Library Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of Global DNA Encoded Library Market vendors

FAQ’s

Q.1 What are the main factors influencing the Global DNA Encoded Library Market?

Q.2 Which companies are the major sources in this industry?

Q.3 What are the market’s opportunities, risks, and general structure?

Q.4 Which of the top Global DNA Encoded Library Market companies compare in terms of sales, revenue, and prices?

Q.5 Which businesses serve as the Global DNA Encoded Library Market’s distributors, traders, and dealers?

Q.6 How are market types and applications and deals, revenue, and value explored?

Q.7 What does a business area’s assessment of agreements, income, and value implicate?

*Note: 1. Source: Coherent Market Insights, Public sources, Desk research 2. We have leveraged AI tools to mine information and compile it

[favouritefab-blog]

Sanitary pad vending machine manufacturer in india

As menstrual hygiene awareness continues to grow across India, more organizations and institutions are installing sanitary pad vending machines to ensure women and girls have easy access to sanitary products. Several manufacturers in India specialize in producing high-quality, reliable, and affordable sanitary pad vending machines. Here’s a list of some of the leading sanitary pad vending machine manufacturers in India.

1. Saral Designs

Overview: Saral Designs is a well-known manufacturer of innovative solutions for menstrual hygiene in India. Their sanitary pad vending machines are designed with ease of use and convenience in mind. Saral also provides smart vending machines with cashless payment options.

Key Products:

Coin-operated sanitary pad vending machines

Smart vending machines with card and mobile payment systems

Machines with large capacity, suitable for schools, offices, and public spaces

Features:

Easy-to-use interface

Durable, long-lasting build

Available in multiple capacities

Location: Mumbai, Maharashtra Website: Saral Designs

2. Vendiman

Overview: Vendiman is a leading manufacturer in the vending solutions space, providing smart and efficient vending machines, including sanitary pad vending machines. Their machines are widely used in public places, malls, and offices across India.

Key Products:

Cashless sanitary pad vending machines

Coin-operated models

Customized vending solutions for different spaces

Features:

Modern design

Cashless payment options (cards, UPI, mobile wallets)

High capacity and low maintenance

Location: Mumbai, Maharashtra Website: Vendiman

3. She Wings

Overview: She Wings focuses on manufacturing sanitary pad vending machines that cater to schools, colleges, and offices. They offer cost-effective solutions for organizations looking to provide free or affordable access to sanitary products.

Key Products:

Manual and coin-operated vending machines

Machines for free sanitary pad distribution

Low-capacity models for schools and small offices

Features:

Simple and easy-to-operate

Affordable pricing

Minimal maintenance required

Location: Delhi Website: She Wings

4. NapiNest

Overview: NapiNest specializes in providing sanitary pad vending machines to educational institutions and public offices. Their machines are designed to ensure easy access to sanitary pads at minimal or no cost, with a focus on promoting menstrual hygiene.

Key Products:

Coin-operated vending machines

Free-dispensing sanitary pad machines

Compact and high-capacity models

Features:

User-friendly operation

Affordable for schools and government offices

Designed for easy installation and maintenance

Location: Chennai, Tamil Nadu Website: NapiNest

5. Shri Rang Enterprise

Overview: Shri Rang Enterprise is a prominent manufacturer of vending machines in India, including sanitary pad vending machines. Their products are designed with durability and simplicity, making them ideal for use in high-traffic areas.

Key Products:

Coin and token-operated sanitary pad vending machines

Wall-mounted machines

Machines with multiple payment methods

Features:

Stainless steel construction for durability

High capacity for public spaces

Easy-to-install wall-mounted designs

Location: Ahmedabad, Gujarat Website: Shri Rang Enterprise

6. Kiosk Technologies

Overview: Kiosk Technologies offers a range of sanitary pad vending machines suited for schools, colleges, and public places. They focus on creating machines that are affordable, easy to use, and highly functional.

Key Products:

Coin-operated sanitary pad vending machines

Cashless and token-based models

High-capacity models for high-traffic areas

Features:

Durable construction

Affordable pricing for institutions

Customizable options available

Location: Hyderabad, Telangana Website: Kiosk Technologies

7. Selex

Overview: Selex is a trusted name in the vending machine industry in India. Their sanitary pad vending machines are known for their reliability, ease of use, and modern payment systems. They cater to a wide range of clients, including schools, offices, and public institutions.

Key Products:

Manual sanitary pad vending machines

Coin and cashless vending options

Customized machines for large institutions

Features:

Cashless payment integration

Durable and reliable build

High-capacity machines for public spaces

Location: Pune, Maharashtra Website: Selex

Conclusion

When choosing a sanitary pad vending machine manufacturer in India, it’s essential to consider factors like capacity, payment methods, durability, and ease of maintenance. Manufacturers like Saral Designs, Vendiman, and She Wings offer a range of solutions, from simple manual machines to advanced cashless vending systems, ensuring that institutions, public places, and offices can provide sanitary pads conveniently and efficiently.

Whether you’re installing machines in schools, public places, or offices, these manufacturers provide reliable solutions to promote menstrual hygiene and improve accessibility to sanitary products.

[tamanna31]

Aptamers Market Share, Supply, Sales, Manufacturers, Competitor and Consumption 2023 to 2030

Aptamers Industry Overview

The global aptamers market size was valued at USD 1.94 billion in 2022 and is expected to grow at a compounded annual growth rate (CAGR) of 24.54% from 2023 to 2030.

Recent advancements in the generation, purification, and drug delivery for killing target cells have attracted the attention of many researchers towards aptamers due to the competitive advantages associated with them. Some of the advantages include small molecular size, low immunogenicity, low cost of manufacturing, and lesser side effects compared to antibodies; may fuel the R&D of novel aptamers, thereby driving market growth. Despite significant efforts, there are currently no highly effective treatments available against COVID-19 infections due to a large number of genetic mutations. However, biotechnological approaches appear to be promising in the treatment of COVID-19.

Gather more insights about the market drivers, restrains and growth of the Aptamers Market

Consequently, nucleic-acid based aptamers & peptide aptamers might be effective against treating COVID-19 infection. Thus, various initiatives are being undertaken by the government to boost the R&D of novel treatment for COVID-19. For instance, in September 2020, the Department of Community & Economic Development awarded a contract of USD 320,000 to Aptagen LLC for the research and development of novel treatment for the COVID-19.

The aptamers based diagnostic kits and assays developed by using SELEX technology have the ability to develop high-affinity neutralizers and bioprobes for monitoring SARS-COV-2 & COVID-19 biomarkers. Therefore, the introduction of diagnostic kits in the market for disease diagnosis is projected to drive market growth. For instance, in December 2021, Achiko AG received approval from the Ministry of Health of the Republic of Indonesia for Aptamex, a COVID-19 diagnostic kit. Aptamex is a second-generation diagnostic kit developed by using DNA aptamer-based technology that is a cost-effective, chemically synthesized, and an emerging diagnostic kit for healthcare.

Aptamers based diagnostic products are the preferred choice among diagnostic and pathology labs for the diagnosis of disease at the cellular level due to their small size, high specificity, selectivity, and efficacy. Thus, increasing prevalence of diseases such as cancer, CVD, and AMD may increase the footfall of patients in labs for the diagnosis of these diseases, consequently, increasing demand for aptamer based diagnostic products. According to Cancer Research UK estimates, around 27.5 million people are expected to be diagnosed with cancer by 2040.

In March 2022, SomaLogic announced the initiation of assaying samples using SomaScan Assay for the European Prospective Investigation into Cancer and Nutrition (EPIC) study by analyzing 210 million protein measurements from 30,000 samples. This will help researchers in predicting cancer by better understanding its nature, which in turn may contribute in market growth by addressing the increased demand.

As of now, Macugen developed by Eyetech Pharmaceuticals, Inc., (currently commercialized by Bausch Health Companies Inc.) is only the U.S. FDA approved (2004) therapeutic aptamer available in the market. It is used for the treatment of age-related muscular degeneration disorder (AMD). Technological advancements in research encourage scientists’ attention towards the development of novel aptamer based therapeutic drugs for the treatment of various diseases. Currently, there are a number of products under different clinical trials including Zimura developed by IVERIC Bio, Inc., for the treatment of patients with drug AMD. Thus, expected approval of this drug may boost the growth of the market over the period.

Browse through Grand View Research's Biotechnology Industry Research Reports.

• The global structural biology & molecular modeling techniques market size was valued at USD 7.13 billion in 2023 and is projected to grow at a CAGR of 15.4% from 2024 to 2030.

• The global targeted DNA RNA sequencing market size was valued at USD 10.12 billion in 2023 and is projected to grow at a CAGR of 19.4% from 2024 to 2030.

Global Aptamers Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the market trends in each of the sub-markets from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the aptamers market on the basis of type, application, and region.

Type Outlook (Revenue, USD Million; 2018 - 2030)

Nucleic Acid Aptamer

Peptide Aptamer

Application Outlook (Revenue, USD Million; 2018 - 2030)

Diagnostics

Therapeutics

Research & Development

Others

Regional Outlook (Revenue, USD Million; 2018 - 2030)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

Australia

Thailand

South Korea

Latin America

Brazil

Mexico

Argentina

MEA

South Africa

Saudi Arabia

UAE

Kuwait

Key Companies & Market Share Insights

Major players are adopting strategies such as modification in the existing product, approval of new products, and mergers & acquisitions for product enhancements and regional expansion to attain a greater market share. For instance, in January 2023, Aptamer Group collaborated with BaseCure Therapeutics for the development of Optimer-targeted therapies. Such initiatives can open new avenues of growth for applications of aptamers in therapeutics. Some of the prominent players in the global aptamers market include:

SomaLogic

Aptamer Group

Aptadel Therapeutics

Base Pair Biotechnologies

Noxxon Pharma

Vivonics Inc.

Aptagen, LLC

TriLink Biotechnologies

Altermune LLC

AM Biotechnologies

Order a free sample PDF of the Aptamers Market Intelligence Study, published by Grand View Research.

[healthcaremarketanalysis]

Global Aptamers Market Size Worth USD 342 million by 2026|

The global aptamers market in terms of revenue was estimated to be worth $151 million in 2021 and is poised to reach $342 million by 2026, growing at a CAGR of 17.7% from 2021 to 2026. 

Download PDF Brochure:

Key Market Players:

Aptamer Group (UK), Raptamer Discovery Group (US), SomaLogic Inc., (US), Aptamer Sciences, Inc. (South Korea), Aptagen, LLC (US), Maravai Lifesciences (US), Kaneka Corporation (Japan), NeoVentures Biotechnology Inc. (Canada), Aptus Biotech (Spain), Base Pair Biotechnologies (US), AMSBIO (UK), Novaptech (France), Bio-Techne (US)

Browse in-depth TOC on "DNA Aptamers Industry"

196 – Tables

38 – Figures

183 – Pages

Growth of aptamers market is attributed to factors such as increase in number of clinical trials for development of aptamer-based therapeutics, increase in awareness about advantages of aptamers as compared to antibodies, rising investment in pharmaceutical R&D, and rising prevalence of chronic and rare diseases to increase the demand for aptamer-based therapeutics and diagnostics.

Lower production cost and higher stability will drive the DNA-based aptamers segment growth

Based on type, the aptamers market is segmented into DNA aptamers, XNA aptamers, and RNA aptamers. The DNA-based aptamers segment dominated the market in 2020. The large share of this segment is attributed to their lower production cost and higher stability compared to other nucleic acid-based aptamers and the wide availability of DNA aptamers.

Request Free Sample Pages:

The therapeutics development segment will continue to dominate the aptamers market during the forecast period

Based on the application, the market is segmented into therapeutics development, research & development, diagnostics, and other applications. The therapeutics development segment dominated the market due to the increasing number of clinical trials evaluating aptamers for new therapies and collaborations among aptamer companies & prominent pharmaceutical and biotechnology firms. The diagnostic segment is projected to grow at the highest CAGR due to the increasing prevalence of chronic diseases and the development of new diagnostic kits to detect cancer and other diseases.

Pharmaceutical & biotechnology companies are the largest end users of aptamers market

Based on end user, the market is segmented into pharmaceutical companies & biotechnology companies, academic & government research institutes, contract research organizations, and other end users. Pharmaceutical & biotechnology companies dominated the market owing to the increasing number of market players offering custom aptamers for use in therapeutics development & rising R&D expenditure. The diagnostic segment will record the highest CAGR during the forecast period due to the development of diagnostic tools for cancer and infectious diseases.

Others segment is expected to witness the highest CAGR during the forecast period

Based on technology, the aptamers market is segmented into SELEX and other technologies. The SELEX technology segment dominated the market in 2020. The segment accounts for a large share of the aptamers market as SELEX is one of the most widely used technologies. The other technologies segment is expected to register the highest CAGR during the forecast period due to the increasing focus on developing technologies for aptamer selection.

North America was the largest regional market for aptamers market in 2020

The global aptamers market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the market. The largest share of North America is attributed to the availability of funds to develop innovative technologies, the presence of prominent market players, and growing collaborations among companies.

Hypothetic Challenges of Aptamers Market in Near Future:

Increased Competition: With the growing popularity of aptamers, more companies are entering the market and competing for market share. This could lead to increased competition and price wars, which could make it difficult for existing companies to remain profitable.

Regulatory Uncertainty: With the technology being relatively new, regulatory frameworks for aptamers are not yet established in many countries. This could lead to uncertainty in the market and could prevent companies from being able to make long-term plans.

Technological Limitations: The current technology behind aptamers is limited in terms of its capabilities. This could lead to a lack of innovation and progress in the market, which could hinder its potential growth.

Cost of Production: The cost of producing aptamers is relatively high due to the complexity of the technology. This could make it difficult for companies to remain competitive and profitable.

Safety Concerns: As with any medical technology, there are always safety concerns surrounding the use of aptamers. This could lead to increased scrutiny and potential legal issues, which could further complicate the market.

Top 3 Use Cases of Aptamers Market:

Diagnostics: Aptamers can be used in various diagnostic applications, such as antigen-antibody assays, DNA/RNA detection, and enzyme assays. Aptamers can also be used to detect drug residues in food and water.

Therapeutics: Aptamers can be used as therapeutic agents to target specific cells and tissues, as well as to deliver drugs directly to their site of action. They can also be used as molecular “scissors” to cleave specific proteins or DNA sequences.

Research: Aptamers are widely used in research applications such as protein structure determination, gene expression profiling, protein-protein interaction studies, and gene silencing. They are also used to study cellular processes such as apoptosis and cell-signalling pathways.

Recent Developments

In August 2021, Aptamer Group, Ltd. and BizCom Japan, Inc. entered into a distribution and marketing agreement to market Optimer discovery and development services in Japan.

In August 2021, Aptamer Group entered a partnership with ProAxsis Limited. As per the partnership, Aptamer Group will develop validated Optimer ligands against critical targets for ProAxsis’s diagnostic assays

In July 2021, Aptamer Sciences, Inc. was selected by the Korean government to support a non-clinical project for a new drug development project for COVID-19 treatment and vaccine and will receive a research grant of about USD 0.51 million for one year through this project.

Get 10% Free Customization on this Report: